Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
The use of generic DAAs for hepatitis C treatment, Freeman et al 2016
The use of generic DAAs for hepatitis C treatment, Freeman et al 2016
Download PDF
June 28, 2016
/
News
Share
the Post
Related
Posts
Asia-Pacific Aids Groups Express Deep Dismay At Conclusion Of Secretly Negotiated Trans-Pacific Partnership Agreement That Threatens Future Access To Affordable Generic Medicines And Sustainable Development Goals
Four Indian generic companies take sub license from MPP on daclatasvir
Simplified HCV Treatment* for Treatment-Naive Patients Without Cirrhosis
IAC a community group in Indonesia demanding national food and drugs authority to expedite registration process of DAA medicines in Indonesia
2018 IAS Brief Document Ending an Epidemic – Prioritizing People Who Inject Drugs in HCV elimination Efforts.
Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C
Availability and Pricing of Generic Sofosbuvir in India – Updated 10 September 2015
Part 2: How is hepatitis C treated?
